Last reviewed · How we verify
Inactivated Influenza Vaccine of GSK
Inactivated Influenza Vaccine of GSK is a Biologic drug developed by Hualan Biological Engineering, Inc.. It is currently in Phase 1 development. Also known as: Fluarix.
At a glance
| Generic name | Inactivated Influenza Vaccine of GSK |
|---|---|
| Also known as | Fluarix |
| Sponsor | Hualan Biological Engineering, Inc. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Immunogenicity and Safety of the Concomitant Administration of OVX836 and Quadrivalent Influenza Vaccine in Healthy Volunteers. (PHASE2)
- Age Differences in Influenza and Herpes Zoster Vaccine Responses (INFLUENZA-SHINGRIX) (PHASE2)
- A Study to Evaluate the Reactogenicity, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Supra-seasonal Universal Influenza Vaccines - Inactivated (SUIVs) (GSK3816302A) in Healthy Adults Aged 18 to 39 Years (PHASE1)
- A Pilot Clinical Study of PET Scanning in Evaluation of Vaccine Reactogenicity (NA)
- Co-Administration of AS03 Adjuvanted A/H7N9 IIV With IIV4 (PHASE2)
- Fluarix/ FluLaval/ Fluarix Quadrivalent/ FluLaval Quadrivalent Vaccine Pregnancy Registry
- Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants (PHASE3)
- Immunogenicity, Safety of GSKs Tdap Vaccine Boostrix When Coadministered With GSKs Influenza Vaccine Fluarix in Adults (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Inactivated Influenza Vaccine of GSK CI brief — competitive landscape report
- Inactivated Influenza Vaccine of GSK updates RSS · CI watch RSS
- Hualan Biological Engineering, Inc. portfolio CI
Frequently asked questions about Inactivated Influenza Vaccine of GSK
What is Inactivated Influenza Vaccine of GSK?
Inactivated Influenza Vaccine of GSK is a Biologic drug developed by Hualan Biological Engineering, Inc..
Who makes Inactivated Influenza Vaccine of GSK?
Inactivated Influenza Vaccine of GSK is developed by Hualan Biological Engineering, Inc. (see full Hualan Biological Engineering, Inc. pipeline at /company/hualan-biological-engineering-inc).
Is Inactivated Influenza Vaccine of GSK also known as anything else?
Inactivated Influenza Vaccine of GSK is also known as Fluarix.
What development phase is Inactivated Influenza Vaccine of GSK in?
Inactivated Influenza Vaccine of GSK is in Phase 1.
Related
- Manufacturer: Hualan Biological Engineering, Inc. — full pipeline
- Also known as: Fluarix
- Compare: Inactivated Influenza Vaccine of GSK vs similar drugs
- Pricing: Inactivated Influenza Vaccine of GSK cost, discount & access